Clinical Trial Update: N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intravenous fenretinide in young patients with recurrent or resistant neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED